Elotuzumab side effects and how to deal with them

Elotuzumab is an immunostimulatory antibody directed against SLAMF7 and is indicated for use in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received 1-3 previous treatments, and with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least two previous treatments. Like most medications, evolizumab may cause some side effects during treatment.

Patients may experience a range of adverse reactions while taking evolizumab. The more common ones are fatigue, diarrhea, fever, constipation, cough, peripheral neuropathy, nasopharyngitis, upper respiratory tract infection, loss of appetite and pneumonia. Although these side effects may not necessarily pose a threat to the patient's life, they will undoubtedly affect the patient's quality of life and treatment experience.

Faced with these possible side effects, patients and doctors need to take proactive measures. Infusion reactions are a problem that requires special attention during evolizumab treatment. Infusion reactions grade 2 or above require permanent discontinuation of the drug. Therefore, drugs such as dexamethasone, diphenhydramine, ranitidine, and acetaminophen should be pre-administered before treatment to reduce the risk of infusion reactions. Regarding the side effect of infection, patients should closely monitor their body temperature and other signs of infection, and seek prompt treatment if infection is detected. During treatment, patients should undergo regular liver function tests. If hepatotoxicity is suspected, use should be stopped immediately.

Although evolizumab may cause some side effects, it plays an important role in the treatment of multiple myeloma. Patients and doctors should fully understand these side effects and how to deal with them to ensure that problems can be discovered and dealt with in a timely manner during treatment, so as to maximize the efficacy of the drug and improve the patient's quality of life.

Reference materials:https://www.drugs.com/